Journey Medical Corp (DERM)
4.21 +0.05 (+1.20%) 11:15 ET [NASDAQ]
4.09 x 1,100 4.24 x 100
Realtime by (Cboe BZX)
4.09 x 1,100 4.24 x 100
Realtime 4.17 +0.01 (+0.24%) 08:48 ET
for Mon, Jan 27th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
Cash Flows From Operating Activities | |||||
Net Income | -16,193 | -13,803 | -10,442 | -3,853 | -1,710 |
Depreciation Amortization | 2,725 | 1,801 | 898 | 7,354 | 6,514 |
Accounts receivable | 3,728 | 4,605 | 5,417 | 12,551 | 19,727 |
Accounts payable and accrued liabilities | -2,635 | -3,480 | -2,803 | -18,639 | -7,726 |
Other Working Capital | -2,302 | -1,425 | 3,113 | -1,655 | 14,034 |
Other Operating Activity | 3,325 | 2,107 | -1,202 | 9,482 | -9,079 |
Operating Cash Flow | $-11,352 | $-10,195 | $-5,019 | $5,240 | $21,760 |
Cash Flows From Investing Activities | |||||
Purchase Sale Intangibles | 0 | 0 | 0 | -5,000 | -5,000 |
Other Investing Activity | 0 | 0 | 0 | -5,000 | -5,000 |
Investing Cash Flow | $0 | $0 | $0 | $-5,000 | $-5,000 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | 0 | 0 | 0 | 28,000 | 28,000 |
Debt Issued | 4,950 | 5,000 | N/A | 15,000 | N/A |
Debt Repayment | -625 | 0 | N/A | -21,000 | -21,000 |
Common Stock Issued | 2,049 | 1,668 | 1,637 | 4,615 | 25 |
Other Financing Activity | 0 | 0 | 0 | -31,419 | -31,039 |
Financing Cash Flow | $6,374 | $6,668 | $1,637 | $-4,804 | $-24,014 |
Beginning Cash Position | 27,439 | 27,439 | 27,439 | 32,003 | 32,003 |
End Cash Position | 22,461 | 23,912 | 24,057 | 27,439 | 24,749 |
Net Cash Flow | $-4,978 | $-3,527 | $-3,382 | $-4,564 | $-7,254 |
Free Cash Flow | |||||
Operating Cash Flow | -11,352 | -10,195 | -5,019 | 5,240 | 21,760 |
Free Cash Flow | -11,352 | -10,195 | -5,019 | 5,240 | 21,760 |